Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Tonghe Pharmaceutical is a specialized pharmaceutical manufacturer based in China and operates as a subsidiary of Chongqing Pharscin Pharmaceutical. The company focuses on the production of high-quality Active Pharmaceutical Ingredients (APIs) and finished dosage forms, particularly in the fields of metabolic diseases, cardiovascular health, and anti-infectives. With GMP-certified facilities, Tonghe supplies essential generic medications such as metformin and amlodipine to both domestic and international markets. The firm integrates research, development, and large-scale chemical synthesis to support the broader supply chain of its parent organization. Their business model emphasizes cost-effective manufacturing and compliance with global regulatory standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Tonghe Pharmaceuticals.